Načítá se...
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
INTRODUCTION: Alzheimer’s disease brains are characterized by extracellular plaques containing the aggregated amyloid β(42) (Aβ(42)) peptide and intraneuronal tangles containing hyperphosphorylated tau. Aβ(42) is produced by sequential processing of the amyloid precursor protein (APP) by β-secretase...
Uloženo v:
| Vydáno v: | Alzheimers Res Ther |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687145/ https://ncbi.nlm.nih.gov/pubmed/26689589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-015-0160-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|